PIRAMAL PHARMA
Back to All Ratios
|
PIRAMAL PHARMA Last 5 Year EV/EBIT History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
EV/EBIT(x) | 33.66 | 59.65 | 7.14 | 3.15 |
What is the latest EV/EBIT ratio of PIRAMAL PHARMA ?
Year | EV/EBIT |
---|---|
Mar2024 | 33.66 |
Mar2023 | 59.65 |
Mar2022 | 7.14 |
Mar2021 | 3.15 |
How is EV/EBIT of PIRAMAL PHARMA Trending?
Years | EV/EBIT | % Change | |
---|---|---|---|
Mar2024 | 33.66 | -43.57 | |
Mar2023 | 59.65 | 735.43 | |
Mar2022 | 7.14 | 126.67 | |
Mar2021 | 3.15 | - |
Other Financial Ratios of PIRAMAL PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/EBIT ratio of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹31,777.0 Cr | -0% | -9.8% | 53.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,692.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,215.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹115,000.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,616.4 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,841.4 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | -0% |
-9.8% |
53.3% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses